Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
Nutrients|December 28, 2021
Higher-Dose DHA Supplementation Modulates Immune Responses in Pregnancy and Is Associated with Decreased Preterm BirthChristina J Valentine, Aiman Q Khan, Alexandra R Brown, et al.
Contemporary Clinical Trials Communications|February 29, 2024
Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer centerXiaosong Shi, Dinesh Pal Mudaranthakam, Jo A Wick, et al.
Bone Marrow Transplantation|September 18, 2002
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaS Giralt, A Aleman, A Anagnostopoulos, et al.
JAMA|July 7, 1993
Outcome after allogeneic bone marrow transplant for leukemia in older adultsO Ringdén, M M Horowitz, R P Gale, et al.
Bone Marrow Transplantation|May 12, 2015
Chronic GvHD-associated serositis and pericarditisJ T Leonard, L F Newell, G Meyers, et al.
Bone Marrow Transplantation|June 18, 1999
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaD Przepiorka, I Khouri, P Thall, et al.
Blood|December 23, 1999
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host diseaseD Przepiorka, N A Kernan, C Ippoliti, et al.
Bone Marrow Transplantation|August 10, 2000
Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)B S Andersson, J Gajewski, M Donato, et al.
Physics in Medicine and Biology|July 2, 2025
Fast Monte Carlo log-based framework for robust 4D dose evaluation in proton therapyA Wochnik, D Borys, G Foltyńska, et al.
Transplantation|December 27, 1996
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimusD Przepiorka, C Ippoliti, I Khouri, et al.
Pageof 25